New figures indicate that prostate cancer diagnoses among men under 50 in England have more than tripled over the past 22 years. In 2023, there were 640 new cases in this age group, a substantial rise from 158 cases in 2001, according to an analysis of NHS England data by the World Cancer Research Fund.
Cancer diagnosed before the age of 50 is classified as 'early-onset.' While concerns about rising cancer rates in younger adults have often focused on bowel cancer, the recent analysis highlights a steeper increase in prostate cancer diagnoses. In 2001, the rate was approximately one case per 100,000 men under 50; by 2023, this rate had climbed to 3.6, representing a 305% increase over 22 years.
Experts suggest that increased awareness and more frequent testing likely contribute to the higher number of diagnoses. However, some also point to potential lifestyle and dietary factors. Professor Roger Kirby, a retired prostate surgeon and co-founder of Prostate Cancer UK, noted that soaring obesity rates and diets high in processed meats, such as bacon, sausages, and burgers, could be playing a role. He specifically mentioned nitrates and nitrites found in some processed meats, which have been linked to an increased risk of bowel cancer.
Despite the rise in diagnoses, experts caution that this trend does not definitively mean younger men are inherently more prone to developing prostate cancer. Professor Prabhakar Rajan, Professor of Urology and Robotic Surgery at Queen Mary University of London, stated that greater awareness, enhanced testing, and changes in diagnostic methods could all be factors. He emphasized that the analysis identifies trends but cannot establish definitive causes.
The World Cancer Research Fund's analysis also revealed notable increases in other cancers among individuals under 50. Bowel cancer cases rose from 1,289 in 2001 to 2,989 in 2023. Kidney cancer more than doubled, from 510 to 1,065 cases annually, while womb cancer increased from 335 to 698 cases. Liver cancer saw a rise from 160 to 278 cases, and pancreatic cancer increased from 255 to 346 cases. Breast cancer remained the most common cancer diagnosed among the analyzed group, with cases increasing by approximately 24% from 6,886 to 8,507.
Dr. Giota Mitrou, the WCRF's executive director of research and policy, expressed concern over the current trajectory, stating that the findings reveal a broader and more complex picture of early-onset cancer involving multiple types beyond just bowel cancer.
These findings emerge amidst a growing debate about prostate cancer screening in the UK. The UK National Screening Committee recently recommended screening only for a select group of men aged 45 to 61 who have a specific genetic mutation and a family history of related cancers. This decision has faced opposition from campaigners, who are urging the government to reconsider.
Prostate cancer is the most common cancer among men in Britain, with an estimated 63,000 cases and 12,000 deaths annually. Health officials recommend that men concerned about their risk should discuss prostate-specific antigen (PSA) blood tests with their doctor. Maintaining a healthy lifestyle, including managing weight and being physically active, is also advised.
Natalia Norori, head of data and evidence at Prostate Cancer UK, noted that the increase in diagnoses partly reflects more men undergoing PSA testing. She added that prostate cancer is projected to become even more prevalent, with over a million people expected to be living with a diagnosis by the end of the 2030s, underscoring the need for government action.